CD79A and celiac disease: One year after the first performance of IgG and IgA antibody testing against gliadin and transglutaminase the repeat tests for these antibodies were negative, which is a further indication that disease management plus a GFD was instrumental in the treatment of this elderly patient with silent celiac disease.